Hypercalcemia of Malignancy and Colorectal Cancer

Overview

Journal World J Oncol

Specialty Oncology

Date 2016 Mar 22

PMID 26998187

Citations 11

Authors

Rodolfo J Galindo

Isabela Romao

Ageliki Valsamis

Stuart Weinerman

Yael Tobi Harris

Affiliations

Soon will be listed here.

Abstract

Our aim is to describe the association between colorectal cancer (CRC) and humoral hypercalcemia of malignancy (HHM). Causes of hypercalcemia of malignancy include parathyroid hormone-related peptide (PTHrP) secretion, local osteolysis, calcitriol production and ectopic parathyroid hormone (PTH) secretion. Hypercalcemia of malignancy in patients with CRCs is a rare scenario. A patient with anal squamous cell carcinoma was admitted with hypercalcemia, suppressed PTH and hypophosphatemia. He was found to have metastatic anal squamous cell carcinoma to the liver. Further evaluation revealed elevated PTHrP and 1,25-dihydroxyvitamin D and low 25-hydroxyvitamin D. Over a 5-month course, the hypercalcemia responded poorly to bisphosphonates, transiently to prednisone, but showed marked improvement with chemotherapy. A review of English language publications in Pubmed and a reference search of retrieved articles revealed 29 cases of CRC causing PTHrP-mediated hypercalcemia. Most patients were middle-aged men (mean ± SD: 56.7 ± 13.4 years), with advanced metastatic cancer (85% with hepatic metastasis) and severe hypercalcemia (mean ± SD: 15.6 ± 1.9 mg/dL, 62% with Ca > 14). This condition is associated with high mortality (79%) and short survival (median 54.5 days, CI: 21 - 168). Despite being uncommon, HHM (PTHrP-mediated) should be considered in patients with metastatic CRC presenting with hypercalcemia. Clinicians should be aware that combined etiologies may be present, particularly in cases of resistant hypercalcemia. Treatment of the underlying malignancy is essential for calcium control.

Citing Articles

Prediagnostic serum calcium concentrations and risk of colorectal cancer development in 2 large European prospective cohorts.

Karavasiloglou N, Hughes D, Murphy N, Schomburg L, Sun Q, Seher V Am J Clin Nutr. 2023; 117(1):33-45.

PMID: 36789942 PMC: 10131343. DOI: 10.1016/j.ajcnut.2022.10.004.

Two-way Road of Kidney and Hypercalcemia: A Narrative Review.

Aghsaeifard Z, Alizadeh R Cardiovasc Hematol Disord Drug Targets. 2022; 22(4):200-206.

PMID: 36475333 DOI: 10.2174/1871529X23666221205143041.

Hypercalcemia of malignancy in metastatic esophageal squamous cell carcinoma with simultaneous PTHrP and calcitriol overproduction: A case report with literature review.

Song R, Bijay Y, Rizk S, Cao S Ann Med Surg (Lond). 2021; 68:102667.

PMID: 34401137 PMC: 8358632. DOI: 10.1016/j.amsu.2021.102667.

Detection of hypokalemia disorder and its relation with hypercalcemia in blood serum using LIBS technique for patients of colorectal cancer grade I and grade II.

Emara E, Song H, Imam H, Elwekeel W, Gao X, Mohammed M Lasers Med Sci. 2021; 37(2):1081-1093.

PMID: 34173122 DOI: 10.1007/s10103-021-03355-5.

Computed tomography-measured bone mineral density as a surrogate marker of survival after resection of colorectal liver metastases.

Ikuta S, Aihara T, Nakajima T, Kasai M, Yamanaka N Ann Transl Med. 2021; 9(1):21.

PMID: 33553314 PMC: 7859742. DOI: 10.21037/atm-20-3751.

References

March R, ULIN R, Puccio C, Savino J, Arlin Z, Ahmed T . Hypercalcemia associated with adenocarcinoma of the rectum. A case report and review of the literature. Anticancer Res. 1991; 11(6):2029-30. View

Gurney H, Grill V, Martin T . Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia. Lancet. 1993; 341(8861):1611-3. DOI: 10.1016/0140-6736(93)90756-7. View

Mozaffarian G . Hypercalcemia associated with malignancies unexplained by bone metastasis. Case reports and review of literature. J Maine Med Assoc. 1969; 60(9):205-7. View

Palvio D, Sorensen F . Stem cell carcinoma of the colon and rectum. Report of two cases and review of the literature. Dis Colon Rectum. 1985; 28(6):440-5. DOI: 10.1007/BF02560233. View

de Souza P, Friedlander M . Humoral hypercalcemia associated with adenocarcinoma of the rectum. A case report and review of the literature. Am J Clin Oncol. 1995; 18(2):126-9. DOI: 10.1097/00000421-199504000-00006. View

Omenn G, Roth S, Baker W . Hyperparathyroidism associated with malignant tumors of nonparathyroid origin. Cancer. 1969; 24(5):1004-11. DOI: 10.1002/1097-0142(196911)24:5<1004::aid-cncr2820240520>3.0.co;2-p. View

Hu M, Glezerman I, Leboulleux S, Insogna K, Gucalp R, Misiorowski W . Denosumab for treatment of hypercalcemia of malignancy. J Clin Endocrinol Metab. 2014; 99(9):3144-52. PMC: 4154084. DOI: 10.1210/jc.2014-1001. View

Thompson J, Paschold E, Levine E . Paraneoplastic hypercalcemia in a patient with adenosquamous cancer of the colon. Am Surg. 2001; 67(6):585-8. View

Sandler L, Winearls C, Fraher L, Clemens T, Smith R, ORIORDAN J . Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. Q J Med. 1984; 53(210):165-80. View

10.

Benit A, Allard J, Rimailho J, Fauvel J, Escourrou G, Vezzosi D . Persistent and moderate hypercalcemia related to an ovarian clear cell adenocarcinoma: Pre- and postoperative parathyroid hormone related-peptide and 1,25-dihydroxyvitamin D3 levels. J Endocrinol Invest. 2006; 29(5):443-9. DOI: 10.1007/BF03344128. View

11.

Sidler B, Alpert L, Henderson J, Deckelbaum R, Amizuka N, Silva J . Amplification of the parathyroid hormone-related peptide gene in a colonic carcinoma. J Clin Endocrinol Metab. 1996; 81(8):2841-7. DOI: 10.1210/jcem.81.8.8768840. View

12.

Chevinsky A, Berelowitz M, Hoover Jr H . Adenosquamous carcinoma of the colon presenting with hypercalcemia. Cancer. 1987; 60(5):1111-6. DOI: 10.1002/1097-0142(19870901)60:5<1111::aid-cncr2820600532>3.0.co;2-1. View

13.

Hoekman K, Tjandra Y, Papapoulos S . The role of 1,25-dihydroxyvitamin D in the maintenance of hypercalcemia in a patient with an ovarian carcinoma producing parathyroid hormone-related protein. Cancer. 1991; 68(3):642-7. DOI: 10.1002/1097-0142(19910801)68:3<642::aid-cncr2820680334>3.0.co;2-a. View

14.

Hernandez J, Shibata D . Paraneoplastic hypercalcemia caused by an invasive squamous cell carcinoma arising from a giant anal condyloma acuminatum. Int J Colorectal Dis. 2008; 24(3):359-60. DOI: 10.1007/s00384-008-0554-5. View

15.

Churilla T, Brereton H, Klem M, Peters C . Vitamin D deficiency is widespread in cancer patients and correlates with advanced stage disease: a community oncology experience. Nutr Cancer. 2012; 64(4):521-5. DOI: 10.1080/01635581.2012.661515. View

16.

Roodman G . Mechanisms of bone metastasis. N Engl J Med. 2004; 350(16):1655-64. DOI: 10.1056/NEJMra030831. View

17.

Asa S, Henderson J, Goltzman D, Drucker D . Parathyroid hormone-like peptide in normal and neoplastic human endocrine tissues. J Clin Endocrinol Metab. 1990; 71(5):1112-8. DOI: 10.1210/jcem-71-5-1112. View

18.

Adams J, Hewison M . Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch Biochem Biophys. 2012; 523(1):95-102. PMC: 3361592. DOI: 10.1016/j.abb.2012.02.016. View

19.

Moll U, Ilardi C, Zuna R, Phillips M . A biologically active parathyroid hormone-like substance secreted by an adenosquamous carcinoma of the transverse colon. Hum Pathol. 1987; 18(12):1287-90. DOI: 10.1016/s0046-8177(87)80415-x. View

20.

Nakayama K, Fukumoto S, Takeda S, Takeuchi Y, Ishikawa T, Miura M . Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia. J Clin Endocrinol Metab. 1996; 81(2):607-11. DOI: 10.1210/jcem.81.2.8636276. View